1. Home
  2. VRE vs HROW Comparison

VRE vs HROW Comparison

Compare VRE & HROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Veris Residential Inc.

VRE

Veris Residential Inc.

HOLD

Current Price

$15.05

Market Cap

1.4B

Sector

Real Estate

ML Signal

HOLD

Logo Harrow Inc.

HROW

Harrow Inc.

HOLD

Current Price

$41.34

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VRE
HROW
Founded
1949
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.4B
IPO Year
1994
N/A

Fundamental Metrics

Financial Performance
Metric
VRE
HROW
Price
$15.05
$41.34
Analyst Decision
Buy
Strong Buy
Analyst Count
4
8
Target Price
$18.25
$68.86
AVG Volume (30 Days)
663.9K
716.4K
Earning Date
10-22-2025
11-10-2025
Dividend Yield
2.13%
N/A
EPS Growth
N/A
N/A
EPS
0.68
N/A
Revenue
$291,348,000.00
$250,042,000.00
Revenue This Year
$6.48
$43.92
Revenue Next Year
N/A
$41.22
P/E Ratio
$23.93
N/A
Revenue Growth
6.39
47.83
52 Week Low
$13.69
$20.85
52 Week High
$18.47
$50.72

Technical Indicators

Market Signals
Indicator
VRE
HROW
Relative Strength Index (RSI) 53.15 58.85
Support Level $14.88 $36.95
Resistance Level $15.18 $41.24
Average True Range (ATR) 0.29 2.64
MACD 0.01 0.52
Stochastic Oscillator 46.20 89.48

Price Performance

Historical Comparison
VRE
HROW

About VRE Veris Residential Inc.

Veris Residential Inc is a fully-integrated, self-administered and self-managed real estate investment trust (REIT). The company owns and operates a real estate portfolio comprised predominantly of multifamily rental properties located mainly in the Northeast and Class A office properties. The company performs substantially all real estate management, leasing, acquisition and development on an in-house basis. The properties are in three states in the Northeast, plus the District of Columbia. The company operates in two industry segments multifamily real estate & services and commercial & other real estate. The majority of revenue is from Multifamily real estate services.

About HROW Harrow Inc.

Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.

Share on Social Networks: